Trentin, F., Gatto, M., Zen, M., Larosa, M., Nalotto, L., Saccon, F., . . . Doria, A. (2018). Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies. Clin Rev Allergy Immunol.
Citación estilo ChicagoTrentin, Francesca, Mariele Gatto, Margherita Zen, Maddalena Larosa, Linda Nalotto, Francesca Saccon, Elisabetta Zanatta, Luca Iaccarino, y Andrea Doria. "Correction To: Effectiveness, Tolerability, and Safety of Belimumab in Patients With Refractory SLE: A Review of Observational Clinical-Practice-Based Studies." Clin Rev Allergy Immunol 2018.
Cita MLATrentin, Francesca, et al. "Correction To: Effectiveness, Tolerability, and Safety of Belimumab in Patients With Refractory SLE: A Review of Observational Clinical-Practice-Based Studies." Clin Rev Allergy Immunol 2018.